Keyphrases
Preventing Infection
100%
Cystic Fibrosis
100%
Pseudomonas Aeruginosa (P. aeruginosa)
100%
Large Trials
66%
Small Clinical Trials
33%
Cochrane
16%
Antigen-antibody
16%
Epitope
16%
Intranasal
16%
Adverse Events
16%
Press Releases
16%
Flagella
16%
Extracted Data
16%
Chronic Pulmonary Infections
16%
Clinical Development
16%
Lung Damage
16%
Genetic Disease
16%
Antibody Titre
16%
PubMed
16%
Randomized Trial
16%
Observation Period
16%
Search Methods
16%
Selection Criteria
16%
Confidence Interval
16%
Chronic Infection
16%
Relative Risk
16%
Vaccine Effectiveness
16%
Lung
16%
Pseudomonas
16%
Placebo Groups
16%
March 2015
16%
Pharmacology, Toxicology and Pharmaceutical Science
Pseudomonas Vaccine
16%
Oral Vaccine
16%